APPLYING EI TO SALUTOGENESIS IN COLLEGIAL RELATIONSHIPS

Collegial relationships, based on professional role interaction and shared values, commitment, and hardship can also be salutogenic. Two nurses who don’t “get along” may find common ground (meaning) in shared commitment to solving a particularly difficult patient problem. A doctor and nurse may find new respect and a deeper level of effectiveness when they use their different approaches together to achieve a common goal, deepening their partnership at the same time patient goals are achieved. The effectiveness of excellent mentors, teachers, and supervisors often rest with their ability to form salutogenic relationships that are very different from friendships or other relationships of equal power.

In collegial relationships, EI ability feeds the salutogenic qualities of a relationship. Identifying emotions, especially those related to conflict like competitiveness, jealousy, defensiveness, and resistance leads to an opportunity to move beyond them and set shared meaning as the primary goal. This is illustrated in a relationship between two ICU nurses who openly acknowledged their dislike of each other. Head-to-head over a deep open wound in their patient’s leg, they finally looked at each other and said, “You will never be my friend, but we both want this thing healed.” This identification of emotions, along with the spoken commitment to a common goal, enabled them to set aside the emotions that were keeping them from working well together. They never did become friends, but their professional relationship, built on their mutual respect and professional work together, nourished them both.

EI, SALUTOGENESIS, AND NURSING RESEARCH

Little research examines EI ability as it affects salutogenesis in nurses specifically, but a great deal of evidence supports the relationship between EI and related concepts, physical and emotional health, self-efficacy, and emotional self-care in moral and spiritual distress. Meta-analysis of general population (including samples greater than 19,000), concluded that EI correlated with emotional and physical health (Kotsou et al., 2018; Martins et al., 2010). Development of EI ability has been correlated with health outcomes in nurses, and several studies identified EI as a mediator in nurses’ stress responses and burnout (Afsar et al., 2017; Hurley et al., 2020; Jurado et al., 2019) (see Chapter 15 for research summary). It is particularly interesting that countries as culturally dissimilar as the United States, Pakistan, Greece, Spain, and China report similar findings.

DEVELOPING EMOTIONAL INTELLIGENCE AND CULTIVATING SALUTOGENESIS

THE PRACTICE OF REFLECTION AND USING THE RELAXATION RESPONSE

As the stories in this chapter suggest, identifying emotions in professional practice—and ways of understanding them, that have particularly rich meaning—is a great way to begin. 

Let us consider the following questions for our writing assignment this week that can start us off on this practice. 

1-When you are at the bedside, what emotional experiences make you feel more human, more deeply alive? 

2-What emotions have the opposite effect, diminishing your humanity?

3-The ability to use emotions to reason is particularly important in this work. 

4-How does what I feel deepen my understanding of this emotion? 

5-How does my understanding of this emotion change how I feel?

APA FORMAT 

NO PLAGIARISM MORE THAN 10%

DUE DATE SEPTEMBER 25, 2023

4 PAGES

REFERENCES NO OLDER THAN 5 YEARS IN APA FORMART

Post your cost comparison document from Unit 2. Assuming you might prescribe this drug for your patient, how would you minimize cost or assist the patient in getting the medication at the lowest cost possible. What resources are available to reduce drug costs? Find at least 2 resources for free or reduced cost medications. Respond to two other student posts as per the discussion board rubric.

This is my paper from week 2

Comparing pharmacological alternatives, prescription, and over-the-counter drugs stand out. A good example is “Lisinopril,” a hypertension treatment, and “Ibuprofen,” a painkiller. Consider 10mg “Lisinopril” prescription medication. Both brand-name and generic versions exist. Retail chains, small pharmacies, and internet platforms charge various prices for Lisinopril, which is also affected by geography in the US. In contrast, “Ibuprofen” is an over-the-counter painkiller available without a prescription. Its range of formulas and amounts makes it affordable and widely used. Comparing the generic and brand-name versions of Lisinopril, which have the same active component but cost less, may show the economic benefits of choosing the generic. This comparison between prescription and OTC drugs shows how regulation, accessibility, and cost affect pharmaceuticals. Starting the prescription drugs, Lisinopril is commonly prescribed for the management of hypertension. For a 10mg dose, let us examine the price differences between brand and generic options at different types of pharmacies in different locations in the United States.

Prescription Drug – Lisinopril 10mg (30 tablets)

1. Large Chain Pharmacy – Walgreens (Chicago, IL):

Brand: Prinivil – Cash Price: $45.00

Generic: Lisinopril – Cash Price: $12.00

2. Grocery Store Associate Pharmacy – Publix (Atlanta, GA):

Brand: Zestril – Cash Price: $43.00

Generic: Lisinopril – Cash Price: $10.00

3. Privately Owned Local Pharmacy – Victory Pharmacy (Seattle, WA):

Brand: Qbrelis – Cash Price: $47.00

Generic: Lisinopril – Cash Price: $11.00

4. Pharmacy Associated with Big Box Store – Walmart (Dallas, TX):

Brand: Prinizide – Cash Price: $50.00

Generic: Lisinopril – Cash Price: $9.00

Lisinopril 10mg (30 pills) price among pharmacies and geolocations gives useful information into pharmaceutical cost trends. The study found that generic Lisinopril is much cheaper than brand-name versions at all drugstore types and locations. Walgreens in Chicago sells Prinivil for $45.00 and Lisinopril for $12.00. Zestril, the brand, costs $43.00 at Publix, an Atlanta supermarket store associate pharmacy, whereas Lisinopril costs $10.00. Victory Pharmacy, a Seattle-based private pharmacy, sells Qbrelis for $47.00 and Lisinopril for $11.00. Walmart in Dallas follows this pattern, selling Prinizide for $50 and Lisinopril for $9.00. The consistent price disparity emphasizes the economic logic of adopting generic products wherever available, particularly for financially strapped people seeking cheaper healthcare. This report highlights the significant influence of pharmacy choice on patient spending, pushing consumers to be cautious and aware of the pharmaceutical market.

Over-the-Counter Drug – Ibuprofen 200mg (100 tablets):

1) Large Chain Pharmacy – CVS (New et al.):

Brand: Advil – Cash Price: $10.00

Generic: Ibuprofen – Cash Price: $7.00

2) Grocery Store Associate Pharmacy – Kroger (Houston, TX):

Brand: Motrin – Cash Price: $9.00

Generic: Ibuprofen – Cash Price: $6.00

3) Privately Owned Local Pharmacy – Greenway Pharmacy (San et al.):

Brand: Nurofen – Cash Price: $11.00

Generic: Ibuprofen – Cash Price: $7.50

4) Pharmacy Associated with Big Box Store – Target (Minneapolis, MN):

Brand: Up & Up – Cash Price: $8.00

Generic: Ibuprofen – Cash Price: $5.00

Ibuprofen 200mg (100 pills) pricing across pharmacies and locales reveals an interesting price difference between brand-name and generic choices. This difference highlights the constant benefit of generic versions, supporting the pharmaceutical industry trend. In huge chain pharmacies like CVS in New York City, Advil costs $10.00, and Ibuprofen costs $7.00. Kroger, a Houston grocery store associate pharmacy, sells Motrin for $9.00 and generic Ibuprofen for $6.00. San Francisco's privately held Greenway Pharmacy follows this approach. Brand-name Nurofen costs $11.00, whereas generic Ibuprofen costs $7.50. Even in 'big box' pharmacy sections, Target in Minneapolis perpetuates the idea with $8.00 Up & Up and $5.00 generic Ibuprofen. The constancy of this pattern supports the economic case for buying generic drugs. This decision saves customers money and emphasizes educated consumption. This research highlights how competition and price tactics shape customer choices in the market. It promotes intelligent pharmaceutical selections and cost-effective solutions by encouraging active healthcare expenditure evaluation.

Comparing brand names with generic prescription and over-the-counter medications shows that generics are cheaper across pharmacies. This cost disparity supports educated consumption by choosing generic versions. The results highlight the importance of pharmacy selection in determining medicine procurement costs as individuals traverse the complicated healthcare environment. The long-term trend shows that well-informed healthcare choices may save money and ensure access to excellent treatments.

  

Instructions: Read the following case study and answer the reflective questions. Please provide rationales for your answers. Make sure to provide citations/references for your answers in APA format with scholarly references no older than 5 years. 

CASE STUDY: Active Labor: Susan Wong 

Mrs. Wong, a first-time mother, is admitted to the birthing suite in early labor after spontaneous rupture of membranes at home. She is at 38 weeks of gestation with a history of abnormal alpha-fetoprotein levels at 16 weeks of pregnancy. 

She was scheduled for ultrasonography to visualize the fetus to rule out an open spinal defect or Down syndrome, but never followed through. Mrs. Wong and her husband disagreed about what to do (keep or terminate the pregnancy) if the ultrasonography indicated a spinal problem, so they felt they did not want this information

. Reflective Questions 

1. As the nurse, what priority data would you collect from this couple to help define relevant interventions to meet their needs? 

2. How can you help this couple if they experience a negative outcome in the birthing suite? What are your personal views on terminating or continuing a pregnancy with a risk of a potential anomaly? What factors may influence your views? 

3. With the influence of the recent Human Genome Project and the possibility of predicting open spinal defects earlier in pregnancy, how will maternity care change in the future? 

Discuss what is happening on a cellular level with the disease process. Be careful to realize that patients have co-morbidities, and you may need to discuss the other diseases impact on the pathophysiology and care of the patient.  Three (3) resources after 2008 are required along with APA format. Add questions to paper

Neoplasia Case Study

You have met a 67 y.o. female patient who presents with c/o dyspnea and a chronic cough for weeks. She is a smoker since she was a teenager. This is a fo9llow-up visit after testing has been completed. Testing completed included:

Pulmonary Function Testing which show a definite blockage in her airflow;

A Chest X-Ray which shows a lesion

Bronchoscopy washings which showed malignant cells.

Histology is a squamous cell carcinoma

Her diagnosis is bronchogenic lung cancer.

1. Why did this patient have a blockage in her airflow?

2. Did her lung cancer metastasize from cancer in another location in her body, or did it arise in her lungs?

3. Why did she develop dyspnea?

4. The lining of the bronchi are normally pseudostratified columnar epithelium, not squamous cell. Why did this patients cancer develop from squamous cells?

This patient is scheduled for surgery, followed by radiation therapy and chemotherapy. Surgery will remove the bulk of the tumor, and the radiotherapy is expected to shrink the remaining tumor cells. The chemotherapy is aimed at mnetastatic liver tumors that were discovered. The patient has stopped smoking.

5. Why did the APN order a liver scan when it was discovered that the patient had bronchogenic carcinoma?

6. Why did the cancer metastasize before she had enough signs and symptoms to see out her physician?

7. Have survival rates for patients with this type of cancer improved or not in recent years with treatment? If so what are the latest survival rates published?

8. What educational information should be shared with this patient?

 Avsar, P., Budri, A., Patton, D., Walsh, S., & Moore, Z. (2022).  Developing algorithm based on activity and mobility for pressure ulcer  risk among older adult residents: Implications for evidence‐based  practice. Worldviews on Evidence-Based Nursing, 19, 112–120. https://doi.org/10.1111/wvn.12545 

here is the article and I need to answer a 15 questions